GSA Capital Partners’s Envoy Medical COCH Stock Holding History

GSA Capital Partners’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,629	Closed	-$8K	–	1799
2026 Q1	$8K	Buy	+12,629	New	+$8.61K	﹤0.01%	1657

Other funds holding COCH

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DCA

DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ACP

Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

GSA Capital Partners's COCH Position: Q2 2026 in Review

GSA Capital Partners sold out of Envoy Medical (COCH) in Q2 2026, closing a stake of 12,629 shares — an estimated $8K sold.

GSA Capital Partners first reported a position in COCH in Q1 2026 and held it in 1 quarter. The position peaked at $8K in Q1 2026. 32 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

GSA Capital Partners reported no remaining Envoy Medical position as of Q2 2026 after selling out during the quarter.
GSA Capital Partners sold 12,629 Envoy Medical shares in Q2 2026, an estimated $8K.
GSA Capital Partners first reported a position in Envoy Medical in Q1 2026 and held it in 1 quarter.
GSA Capital Partners's Envoy Medical position peaked at $8K in Q1 2026.
32 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.